Evidence map›Paper›PMID 40650970›Full record

ArticleNucleic acids research2025

Design of mismatch closure for enhanced specificity in DNA strand displacement reactions.

Hongyan Yu, Xiaole Han, Li Zhang, Na Yin, Li Wang, Ke Lv, Yongchang Wu, Dan Bai, Weitao Wang, Ying Huang and 6 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Hongyan YuKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, PR China.ORCID 0000-0002-5022-9861
Xiaole HanKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, PR China.
Li ZhangKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, PR China.
Na YinKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, PR China.
Li WangThe Center for Clinical Molecular Medical Detection, Biobank Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China.ORCID 0000-0003-3379-2721
Ke LvDepartment of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China.
Yongchang WuKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, PR China.
Dan BaiKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, PR China.
Weitao WangKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, PR China.
Ying HuangThe Center for Clinical Molecular Medical Detection, Biobank Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China.
Xingping HuThe Center for Clinical Molecular Medical Detection, Biobank Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China.
Zhi WengState Key Laboratory of Oncogenes and Related Genes, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200030, PR China.
Chenlu ZhangKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, PR China.
Gang YangDepartment of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China.
Tingmei ChenKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, PR China.
Guoming XieKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, PR China.ORCID 0000-0003-3340-7133

Funding

Chongqing Medical University BJRC202315National Key R&D Program of China 2022YFC2603800National Natural Science Foundation of China 82172369National Natural Science Foundation of China 82372351
6 · The paper itself

Abstract

Specific and sensitive DNA hybridization plays a key role in biotechnology, nanotechnology, and medical technology. However, traditional DNA hybridization-based strategies often require careful tuning of the binding affinity of the probe to attain a trade-off between specificity and sensitivity. Herein, we proposed energy barrier-gated dynamic selectivity to overcome this limitation. The mismatch closure-mediated strand displacement reaction (mcSDR) induces structural constraints through helper strand binding at mismatched sites, resulting in the displacement of the mismatch target requires overcoming an additional activation energy barrier, whereas the perfect match target proceeds via a normal pathway. The mcSDR has been thermodynamically and kinetically demonstrated to be able to balance specificity and sensitivity simultaneously. The energy barrier height can be programmably adjusted by design of helper strand and works in synergy with the toehold exchange strategy to achieve multi-parameter optimization. The superior properties of the mcSDR facilitated the identification of 12 mutation types exhibits excellent specificity in 28 clinically relevant single nucleotide variations. By combining polymerase chain reaction, mutations with an abundance of 0.1% were successfully detected in plasmid samples, and a triple mcSDR was successfully constructed. Clinical validation of 95 glioma and 93 colorectal cancer samples showed that IDH1 and KRAS mutations were 100% consistent with Sanger sequencing. The energy barrier-driven identification mechanism and operational simplicity of mcSDR make it promising for wide applications in biomedical research, molecular diagnosis, and precision medicine.

Indexed as

Base Pair MismatchDNANucleic Acid HybridizationColorectal NeoplasmsHumansMutationPolymorphism, Single NucleotideProto-Oncogene Proteins p21(ras)ThermodynamicsDNAProto-Oncogene Proteins p21(ras)

Identifiers

PMID40650970
PMCPMC12255293

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.